- Home
- CRVO
CRVO
CervoMed Inc.
as of 02-27-2026 3:55pm EST
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 47.7M | IPO Year: | 2011 |
| Target Price: | $21.50 | AVG Volume (30 days): | 79.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.22 | EPS Growth: | -97.91 |
| 52 Week Low/High: | $1.92 - $16.50 | Next Earning Date: | N/A |
| Revenue: | $9,737,974 | Revenue Growth: | 36.29% |
| Revenue Growth (this year): | -47.99% | Revenue Growth (next year): | -81.88% |
| P/E Ratio: | -3.61 | Index: | N/A |
| Free Cash Flow: | -16978650.0 | FCF Growth: | N/A |
AI-Powered CRVO Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare CRVO vs Leading Stocks
See how CRVO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CRVO CervoMed Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.